New hope for stomach cancer: experimental combo trial launches
NCT ID NCT04725994
First seen Apr 23, 2026 · Last updated Apr 29, 2026 · Updated 1 time
Summary
This study tests a new drug called IDX-1197 combined with standard chemotherapy (XELOX or irinotecan) in people with advanced stomach cancer. The goal is to find the safest dose and see if the combination helps control the cancer. About 87 adults with advanced or metastatic stomach cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
-
Astera Cancer Care
East Brunswick, New Jersey, 08816, United States
-
Beijing Cancer Hospital
Beijing, China
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dong-A University Hospital
Busan, 49201, South Korea
-
Hematology Oncology Clinic Baton Rouge / Sarah Cannon
Baton Rouge, Louisiana, 70809, United States
-
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
-
Korea University Anam Hospital
Seoul, 02841, South Korea
-
Korea University Guro Hospital
Seoul, 08308, South Korea
-
Samsung Medical Center
Seoul, South Korea
-
Seoul National University Bundang Hospital
Seongnam, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
-
Shanghai East Hospital
Shanghai, China
-
The Sixth Affiliated Hospital of Sun Yat-Sen University
Guangzhou, China
-
USC Norris Comp. Cancer Ctr Hospital
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.